UNSPSC 41142073: Urinary urobilinogen (nonquantitative) test system

In this classification, Urinary urobilinogen (nonquantitative) test system connotes a device used to measure Urinary urobilinogen (nonquantitative) levels. US FDA regulates Urinary urobilinogen (nonquantitative) test system under 21 CFR 862.1785 and under FDA product code CDM.

UNSPSC 41142073 Urinary urobilinogen (nonquantitative) test system is a Commodity code covering diagnostic testing kits and reagents used in forensic, toxicology, and public health laboratory operations. Recent state and local opportunities show activity focused on immunoassay reagent kits for drug screening and certified reference standards for method validation and evidentiary sample analysis, rather than urinary urobilinogen testing specifically. Issuing bodies include state law enforcement and forensic agencies (Texas Department of Public Safety, Texas Department of Criminal Justice), state health departments (Texas Health and Human Services Commission, Illinois Department of Financial and Professional Regulation), and county-level forensic laboratories (Pinellas County, Florida). Work solicited under related codes spans Direct ELISA testing kits for substance analysis across multiple drug classes, certified reference materials meeting ISO/IEC 17025 accreditation standards with purity specifications, and laboratory equipment for toxicology and drug analysis units.

Recent opportunities span Texas, Florida, and Illinois. The Texas Department of Public Safety issued IFB 405-26R0008445A on July 9, 2026, for immunalysis reagent kits across 12 line items of Direct ELISA testing kits for cannabinoids, opiates, PCP, amphetamines, and other substances, with bids due July 23, 2026. Pinellas County, Florida, in partnership with the Florida Department of Law Enforcement, posted Invitation to Quote #26-0305-ITQ on April 23, 2026, for 131 line items of certified drug standards meeting ISO 17034:2016 standards with delivery by June 1, 2026, funded through the Paul Coverdell Forensic Sciences Improvement Act Program at approximately $49,034 for equipment and supplies. The Texas Health and Human Services Commission solicited QIAxcel and QIAamp DNA screening kits under IFB HHS0016902v2 with historical spend guidance of $25,050 to $30,000 annually. The code shows modest recent activity concentrated in forensic and laboratory testing operations rather than clinical urobilinogen screening.